Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

InspireMD, Inc. Director's Dealing 2016

Jan 28, 2016

34187_dirs_2016-01-28_cba78595-5746-4f62-bca1-2bc9c226e904.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2016-01-26

Reporting Person: Stuka Paul (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-01-26 Common Stock A 1 Acquired 1 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-01-26 Options (right to buy) $78.00 D 2500 Disposed 2021-08-08 Common Stock (2500) Direct
2016-01-26 Options (right to buy) $31.60 D 1250 Disposed 2022-06-18 Common Stock (1250) Direct
2016-01-26 Options (right to buy) $31.00 D 5000 Disposed 2024-01-29 Common Stock (5000) Direct
2016-01-26 Options (right to buy) $27.50 D 7500 Disposed 2023-05-09 Common Stock (7500) Direct
2016-01-26 Options (right to buy) $7.80 D 4637 Disposed 2025-01-05 Common Stock (4637) Direct
2016-01-26 Options (right to buy) $7.20 D 5409 Disposed 2025-01-26 Common Stock (5409) Direct

Footnotes

F1: On January 26, 2016, the Issuer and the Reporting Person entered into that certain Option Cancellation and Release Agreement, pursuant to which the parties agreed to the cancellation of certain stock options previously granted to the Reporting Person in exchange for one (1) share of common stock as consideration.

F2: This option was previously reported as covering 25,000 shares at an exercise price of $7.8 per share, but was adjusted to reflect the the 1-for-10 reverse stock split that occurred on October 1, 2015.

F3: This option is exercisable in three equal annual installments. The first installment became exercisable on August 8, 2012, the second installment became on August 8, 2013 and the third installment became exercisable on August 8, 2014.

F4: This option was previously reported as covering 12,500 shares at an exercise price of $3.16 per share, but was adjusted to reflect the 1-for-10 reverse stock split that occurred on October 1, 2015.

F5: This option is exercisable in three equal annual installments. The first installment became exercisable on June 18, 2013, the second installment became exercisable on June 18, 2014 and the third installment became exercisable on June 18, 2015.

F6: This option was previously reported as covering 50,000 shares at an exercise price of $3.1 per share, but was adjusted to reflect the 1-for-10 reverse stock split that occurred on October 1, 2015.

F7: This option is exercisable in three equal annual installments. The first installment became exercisable on January 29, 2015, the second installment would have become exercisable on January 29, 2016 and the third installment would have become exercisable on January 29, 2017, provided that the Reporting Person is providing services to the Issuer or its subsidiaries or affiliates on January 29, 2016, and January 29, 2017, as applicable.

F8: This option was previously reported as covering 75,000 shares at an exercise price of $2.75 per share, but was adjusted to reflect the 1-for-10 reverse stock split that occurred on October 1, 2015.

F9: This option is exercisable in three equal annual installments. The first installment became exercisable on May 9, 2014, the second installment became exercisable on May 9, 2015 and the third installment would have become exercisable on May 9, 2016, provided that the Reporting Person is providing services to the Issuer or its subsidiaries or affiliates on May 9, 2016.

F10: This option was previously reported as covering 46,367 shares at an exercise price of $0.78 per share, but was adjusted to reflect the 1-for-10 reverse stock split that occurred on October 1, 2015.

F11: This option was previously reported as covering 54,088 shares at an exercise price of $0.72 per share, but was adjusted to reflect the 1-for-10 reverse stock split that occurred on October 1, 2015.

F12: This option would have vested in three equal annual installments, with 1/3 becoming exercisable on each of January 26, 2016, January 26, 2017 and January 26, 2018, subject to the Reporting Person's continued service.